New Jersey compounding pharmacy recalls all products, fearing mold contamination

March 18, 2013

Med Prep Consulting, Inc., a compounding pharmacy in Tinton Falls, NJ, is voluntarily recalling all lots of compounded products from its facility for fear of mold contamination, according to an FDA press release.

Med Prep Consulting, Inc., a compounding pharmacy in Tinton Falls, N.J., is voluntarily recalling all lots of compounded products from its facility for fear of mold contamination, according to an FDA press release.

"The level of recall is to the user, that is, regional hospital pharmacies and related departments, and physician’s office practices," the statement said. "The recall resulted from the pharmacy being notified by a Connecticut hospital, that it observed visible particulate contaminants in 50 mL bags of magnesium sulfate 2GM in dextrose 5% in water, 50 mL for injection intravenous solution confirmed to be mold."

The lots were "unique and distinct" and only dispensed to the Connecticut Hospital. As of March 17, five contaminated bags were discovered, but no injuries or illnesses had been reported.

"Administration of an intravenous product found to be contaminated with mold, could result in a fatal infection in a broad array of patients," the release stated.

FDA recently released the results of the inspection observations of 15 pharmacies.

Although 2 of the 15 pharmacies were in New Jersey, Med Prep Consulting was not one of them.

Med Prep offers sterile compounding and is a specialty intravenous pharmacy, according to its website.

All facilities that received Med Prep compounded products were notified and have been instructed to send the medication back to the pharmacy.

This recall comes just as the news surrounding the nationwide meningitis outbreak in October is winding down. The outbreak stemmed from contaminated medication produced by the New England Compounding Center.

Check these out, too…

"60 Minutes'" coverage on meningitis tragedy doesn't tell complete story, NCPA says

Debate surfaces over preferred treatments for fungal meningitis outbreak

Details illuminate start of fungal meningitis outbreak

Did FDA have authority to shut down NECC before meningitis outbreak?